Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1000)	6/9/2005 11:32:04 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

SCLN Has continued its upward move, apparently due to the insiders support and not being affected by A.G.'s usual depressing factor on the market.<g> The stock seems ready to test its Oct.29 H at the 4.86 level in spite of the unimproved outlook for a lower loss in the near horizon.<g> The stock is up another 13% today.There are some reports of "italian investors" buying another 600Ks. Their ZADAXIN has been approved in many countries including China for treatment of hepatitis B & C and is in a PII in the US. SCLN also has a PII going on in Japan and a PII in Europe for MM and 2 PIIs in US for Ca of liver. There are also some trials going on in Mexico and Taiwan. As previously mentioned the Debt/Equt. Ratio is low and the Co. probably has enough cash to complete the current trials.It seems that some insiders have an enthusiastic opinion about the final results of some of these trials.<g> bigcharts.marketwatch.com Bernard